Thank you, New York Times, for asking ‘Who is behind these [psychedelic] studies? Where does the money come from?’
The study highlighted in this well-written article adds to a growing body of research into whether using the synthetic, psychoactive drug MDMA (street names “Ecstasy” or “Molly”) in conjunction with psychotherapy, can improve outcomes in PTSD. 1) Does the story adequately discuss the costs of the intervention? Not Satisfactory 2) Does the story adequately quantify…
Recent Comments